Additive effects of HLA alleles and innate immune genes determine viral outcome in HCV infection.

BACKGROUND: Chronic HCV infection is a leading cause of liver-related morbidity globally. The innate and adaptive immune responses are thought to be important in determining viral outcomes. Polymorphisms associated with the IFNL3 (IL28B) gene are strongly associated with spontaneous clearance and tr...

Full description

Bibliographic Details
Main Authors: Fitzmaurice, K, Hurst, J, Dring, M, Rauch, A, McLaren, P, Günthard, H, Gardiner, C, Klenerman, P
Format: Journal article
Language:English
Published: BMJ Publishing Group 2015
_version_ 1826303552585203712
author Fitzmaurice, K
Hurst, J
Dring, M
Rauch, A
McLaren, P
Günthard, H
Gardiner, C
Klenerman, P
author_facet Fitzmaurice, K
Hurst, J
Dring, M
Rauch, A
McLaren, P
Günthard, H
Gardiner, C
Klenerman, P
author_sort Fitzmaurice, K
collection OXFORD
description BACKGROUND: Chronic HCV infection is a leading cause of liver-related morbidity globally. The innate and adaptive immune responses are thought to be important in determining viral outcomes. Polymorphisms associated with the IFNL3 (IL28B) gene are strongly associated with spontaneous clearance and treatment outcomes. OBJECTIVE: This study investigates the importance of HLA genes in the context of genetic variation associated with the innate immune genes IFNL3 and KIR2DS3. DESIGN: We assess the collective influence of HLA and innate immune genes on viral outcomes in an Irish cohort of women (n=319) who had been infected from a single source as well as a more heterogeneous cohort (Swiss Cohort, n=461). In the Irish cohort, a number of HLA alleles are associated with different outcomes, and the impact of IFNL3-linked polymorphisms is profound. RESULTS: Logistic regression was performed on data from the Irish cohort, and indicates that the HLA-A*03 (OR 0.36 (0.15 to 0.89), p=0.027) -B*27 (OR 0.12 (0.03 to 0.45), p=<0.001), -DRB1*01:01 (OR 0.2 (0.07 to 0.61), p=0.005), -DRB1*04:01 (OR 0.31 (0.12 to 0.85, p=0.02) and the CC IFNL3 rs12979860 genotypes (OR 0.1 (0.04 to 0.23), p<0.001) are significantly associated with viral clearance. Furthermore, DQB1*02:01 (OR 4.2 (2.04 to 8.66), p=0.008), KIR2DS3 (OR 4.36 (1.62 to 11.74), p=0.004) and the rs12979860 IFNL3 'T' allele are associated with chronic infection. This study finds no interactive effect between IFNL3 and these Class I and II alleles in relation to viral clearance. There is a clear additive effect, however. Data from the Swiss cohort also confirms independent and additive effects of HLA Class I, II and IFNL3 genes in their prediction of viral outcome. CONCLUSIONS: This data supports a critical role for the adaptive immune response in the control of HCV in concert with the innate immune response.
first_indexed 2024-03-07T06:04:26Z
format Journal article
id oxford-uuid:ed57bf67-36e4-483c-90ab-33913485f021
institution University of Oxford
language English
last_indexed 2024-03-07T06:04:26Z
publishDate 2015
publisher BMJ Publishing Group
record_format dspace
spelling oxford-uuid:ed57bf67-36e4-483c-90ab-33913485f0212022-03-27T11:24:23ZAdditive effects of HLA alleles and innate immune genes determine viral outcome in HCV infection.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:ed57bf67-36e4-483c-90ab-33913485f021EnglishSymplectic Elements at OxfordBMJ Publishing Group2015Fitzmaurice, KHurst, JDring, MRauch, AMcLaren, PGünthard, HGardiner, CKlenerman, PBACKGROUND: Chronic HCV infection is a leading cause of liver-related morbidity globally. The innate and adaptive immune responses are thought to be important in determining viral outcomes. Polymorphisms associated with the IFNL3 (IL28B) gene are strongly associated with spontaneous clearance and treatment outcomes. OBJECTIVE: This study investigates the importance of HLA genes in the context of genetic variation associated with the innate immune genes IFNL3 and KIR2DS3. DESIGN: We assess the collective influence of HLA and innate immune genes on viral outcomes in an Irish cohort of women (n=319) who had been infected from a single source as well as a more heterogeneous cohort (Swiss Cohort, n=461). In the Irish cohort, a number of HLA alleles are associated with different outcomes, and the impact of IFNL3-linked polymorphisms is profound. RESULTS: Logistic regression was performed on data from the Irish cohort, and indicates that the HLA-A*03 (OR 0.36 (0.15 to 0.89), p=0.027) -B*27 (OR 0.12 (0.03 to 0.45), p=<0.001), -DRB1*01:01 (OR 0.2 (0.07 to 0.61), p=0.005), -DRB1*04:01 (OR 0.31 (0.12 to 0.85, p=0.02) and the CC IFNL3 rs12979860 genotypes (OR 0.1 (0.04 to 0.23), p<0.001) are significantly associated with viral clearance. Furthermore, DQB1*02:01 (OR 4.2 (2.04 to 8.66), p=0.008), KIR2DS3 (OR 4.36 (1.62 to 11.74), p=0.004) and the rs12979860 IFNL3 'T' allele are associated with chronic infection. This study finds no interactive effect between IFNL3 and these Class I and II alleles in relation to viral clearance. There is a clear additive effect, however. Data from the Swiss cohort also confirms independent and additive effects of HLA Class I, II and IFNL3 genes in their prediction of viral outcome. CONCLUSIONS: This data supports a critical role for the adaptive immune response in the control of HCV in concert with the innate immune response.
spellingShingle Fitzmaurice, K
Hurst, J
Dring, M
Rauch, A
McLaren, P
Günthard, H
Gardiner, C
Klenerman, P
Additive effects of HLA alleles and innate immune genes determine viral outcome in HCV infection.
title Additive effects of HLA alleles and innate immune genes determine viral outcome in HCV infection.
title_full Additive effects of HLA alleles and innate immune genes determine viral outcome in HCV infection.
title_fullStr Additive effects of HLA alleles and innate immune genes determine viral outcome in HCV infection.
title_full_unstemmed Additive effects of HLA alleles and innate immune genes determine viral outcome in HCV infection.
title_short Additive effects of HLA alleles and innate immune genes determine viral outcome in HCV infection.
title_sort additive effects of hla alleles and innate immune genes determine viral outcome in hcv infection
work_keys_str_mv AT fitzmauricek additiveeffectsofhlaallelesandinnateimmunegenesdetermineviraloutcomeinhcvinfection
AT hurstj additiveeffectsofhlaallelesandinnateimmunegenesdetermineviraloutcomeinhcvinfection
AT dringm additiveeffectsofhlaallelesandinnateimmunegenesdetermineviraloutcomeinhcvinfection
AT raucha additiveeffectsofhlaallelesandinnateimmunegenesdetermineviraloutcomeinhcvinfection
AT mclarenp additiveeffectsofhlaallelesandinnateimmunegenesdetermineviraloutcomeinhcvinfection
AT gunthardh additiveeffectsofhlaallelesandinnateimmunegenesdetermineviraloutcomeinhcvinfection
AT gardinerc additiveeffectsofhlaallelesandinnateimmunegenesdetermineviraloutcomeinhcvinfection
AT klenermanp additiveeffectsofhlaallelesandinnateimmunegenesdetermineviraloutcomeinhcvinfection